BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10755598)

  • 1. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma.
    Stoll C; Baretton G; Ahrens C; Löhrs U
    Virchows Arch; 2000 Feb; 436(2):102-8. PubMed ID: 10755598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.
    Ito T; Fujieda S; Tsuzuki H; Sunaga H; Fan G; Sugimoto C; Fukuda M; Saito H
    Cancer Lett; 1999 Jun; 140(1-2):81-91. PubMed ID: 10403545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
    Stoll C; Baretton G; Löhrs U
    Virchows Arch; 1998 Nov; 433(5):427-33. PubMed ID: 9849857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.
    Veneroni S; Silvestrini R; Costa A; Salvatori P; Faranda A; Molinari R
    Oral Oncol; 1997 Nov; 33(6):408-13. PubMed ID: 9509124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
    Izawa H; Yonemitsu N; Shin T; Sugihara H
    Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations.
    Lo Muzio L; Mignogna MD; Pannone G; Rubini C; Grassi R; Nocini PF; Ferrari F; Serpico R; Favia G; De Rosa G; Maiorano E
    Oncol Rep; 2003; 10(2):285-91. PubMed ID: 12579259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Ki-67 and p53 immunoexpression in the differential diagnosis of oral necrotizing sialometaplasia and squamous cell carcinoma.
    Dadfarnia T; Mohammed BS; Eltorky MA
    Ann Diagn Pathol; 2012 Jun; 16(3):171-6. PubMed ID: 22197541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas.
    Marioni G; Bedogni A; Giacomelli L; Ferraro SM; Bertolin A; Facco E; Staffieri A; Marino F
    Acta Otolaryngol; 2005 Nov; 125(11):1218-23. PubMed ID: 16353406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
    Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
    Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy.
    Tatemoto Y; Osaki T; Yoneda K; Yamamoto T; Ueta E; Kimura T
    Pathol Res Pract; 1998; 194(12):821-30. PubMed ID: 9894247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic and predictive value of koilocytosis, expression of e6 hpv types 16/18, p16ink4a, p53 in locally advanced squamous cell carcinomas of oral cavity and oropharynx, associated with human papillomavirus].
    Riaboshapka AN
    Georgian Med News; 2014 Nov; (236):48-55. PubMed ID: 25541826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.
    Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
    Pathol Int; 1998 Jan; 48(1):41-6. PubMed ID: 9589463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma.
    Yamazaki Y; Chiba I; Hirai A; Satoh C; Sakakibara N; Notani K; Iizuka T; Totsuka Y
    Head Neck; 2005 Aug; 27(8):676-81. PubMed ID: 15957194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feasibility of DNA impulse cytophotometry (ICP) in the diagnosis of squamous cell cancers of the oral cavity and oropharynx].
    Adler D; Feichter GE; Maier H
    Laryngol Rhinol Otol (Stuttg); 1986 Apr; 65(4):187-90. PubMed ID: 3713395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
    Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
    Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.